Goldman Sachs’s Tevogen Inc TVGN Stock Holding History

Goldman Sachs’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.2K	Buy	+14,163	New	+$113K	﹤0.01%	6360
2026 Q1	–	Sell	-5,474	Closed	-$90.6K	–	7067
2025 Q4	$90.6K	Buy	5,474 +3,052	+126%	+$79.3K	﹤0.01%	6206
2025 Q3	$95.1K	Buy	2,422 +820	+51%	+$40.3K	﹤0.01%	6088
2025 Q2	$100K	Buy	1,602 +507	+46%	+$28.9K	﹤0.01%	5817
2025 Q1	$59.1K	Sell	1,095 -468	-30%	-$30.8K	﹤0.01%	5867
2024 Q4	$80.5K	Buy	1,563 +831	+114%	+$54.1K	﹤0.01%	5799
2024 Q3	$13.5K	Buy	+732	New	+$21.4K	﹤0.01%	5691
2022 Q3	–	Sell	-4,327	Closed	-$2.17M	–	6570
2022 Q2	$2.17M	Hold	4,327	–	–	﹤0.01%	3978
2022 Q1	$2.16M	Buy	+4,327	New	+$2.15M	﹤0.01%	4193

Other funds holding TVGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Goldman Sachs's TVGN Position: Q2 2026 in Review

Goldman Sachs opened a new position in Tevogen Inc (TVGN) in Q2 2026: 14,163 shares worth $80.2K. The stake represents ﹤0.01% of the portfolio and ranks #6360 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in TVGN as recently as Q4 2025.

Goldman Sachs first reported a position in TVGN in Q1 2022 and has held it in 9 quarters since. The position peaked at $2.17M in Q2 2022. 31 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

Goldman Sachs held 14,163 shares of Tevogen Inc worth $80.2K as of Q2 2026.
Tevogen Inc was a new Goldman Sachs position in Q2 2026.
Tevogen Inc made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6360 holding.
Goldman Sachs first reported a position in Tevogen Inc in Q1 2022 and has held it in 9 quarters since.
Goldman Sachs's Tevogen Inc position peaked at $2.17M in Q2 2022.
31 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.